Skip to content

HISTORY

In 2017 a project was launched by a team of Diana Jung, MS, Dr. David Bull, MD, and Dr. Youngwook Won, Ph.D. at the University of Arizona College of Medicine to optimize sugar metabolism in the human body. The objective of this project was to create a natural means for reducing levels of sugar/fats in the fat cells without the imposition of the health risks and the often severe side effects posed by anti-obesity drugs. The team was well aware of the negative effects of elevated levels of sugar on aging, immunity, risk of tumor, heart diseases, and obesity, the latter of which is now reaching pandemic proportions in the USA and other countries.

This research undertaken led to the discover of OBSTO Peptide with its unique activities